Research.Patient.info
Differentiated Thyroid Cancer research hub
3 indexed studies · 1 currently recruiting
- recruitingNA
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
This study looks at whether removing part of the thyroid, instead of all of it, is a good and safe option for people with low-risk thyroid cancer. It aims to see if less surgery is just as effective and more cost-effective.
United Kingdom - active not recruitingPHASE3
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
This study compares a new drug, cabozantinib, with a dummy drug (placebo) for differentiated thyroid cancer that has continued to grow despite previous treatments. It aims to see if cabozantinib can slow down the cancer's progression.
United States · Argentina · Australia - active not recruitingPHASE1
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
This study is testing two anti-cancer drugs, cabozantinib and atezolizumab, alone and together, for various advanced cancers. It aims to find a safe combination dose and see how well it works and any side effects.
United States · Australia · Belgium